PEAK PERFORM INNOVA Trademark

Trademark Overview


On Wednesday, September 3, 2025, a trademark application was filed for PEAK PERFORM INNOVA with the United States Patent and Trademark Office. The USPTO has given the PEAK PERFORM INNOVA trademark a serial number of 99371319. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 23, 2026. This trademark is owned by PEAK PERFORM INNOVA (SUZHOU) CO., LTD.. The PEAK PERFORM INNOVA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of medicines; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Providing medical research information in the field of pharmaceuticals; Research and development of pharmaceutical preparations for treating malignant tumours; Development of pharmaceutical preparations and medicines; Research in the field of artificial intelligence (AI); Design, maintenance, development and updating of computer software; Providing on-line non-downloadable software using artificial intelligence (AI) for the provision of drug development models in the chemical, pharmaceutical, biochemical industries; Drug discovery services
peak perform innova

General Information


Serial Number99371319
Word MarkPEAK PERFORM INNOVA
Filing DateWednesday, September 3, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, February 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLEThe Chinese characters in this mark transliterate to PU NUO ZHI YAO and this means JADE PROMISE INTELLIGENCE MEDICINE in English.
Description of MarkThe mark consists of a shaded circle with a series of straight lines and a dot inside, to the right of the circle appearing four Chinese characters above a horizontal line above the stylized wording “Peak Perform Innova”.
Goods and ServicesResearch and development of medicines; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Providing medical research information in the field of pharmaceuticals; Research and development of pharmaceutical preparations for treating malignant tumours; Development of pharmaceutical preparations and medicines; Research in the field of artificial intelligence (AI); Design, maintenance, development and updating of computer software; Providing on-line non-downloadable software using artificial intelligence (AI) for the provision of drug development models in the chemical, pharmaceutical, biochemical industries; Drug discovery services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePEAK PERFORM INNOVA (SUZHOU) CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSUZHOU AREA, JIANGSU 215123
CN

Trademark Events


Event DateEvent Description
Wednesday, September 3, 2025NEW APPLICATION ENTERED
Wednesday, September 3, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 23, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, January 24, 2026ASSIGNED TO EXAMINER
Monday, February 23, 2026NON-FINAL ACTION WRITTEN
Monday, February 23, 2026NON-FINAL ACTION E-MAILED
Monday, February 23, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED